EUVIMEDEUVIMED entdecken
Crossref

Botulinum Toxin Treatment for Adductor Laryngeal Dystonia Reduces Speech‐Related Cognitive Load

Joseph Chang iD, Nede Ovbiebo, Christine H Lo, Madeline Knutson, Cara Sauder, Emily Wilson, Tanya K Meyer iD, Tanya L Eadie

The Laryngoscope · 2026-05 · 136 (5) · 2242-2247

DOI: 10.1002/lary.70310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 12.12.2025. Verfasst von Joseph Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology- Head and Neck Surgery, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Laryngeal Diseases, Cognition, Dystonia, Botulinum Toxins, Type A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Center for Advancing Translational Science of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Botulinum toxin (BTX) treatment has previously been shown to improve voice quality, quality of life, and the physical component of vocal effort in adductor laryngeal dystonia (ADLD) patients. More recently, cognitive load has been identified as a contributor to vocal effort in ADLD patients. This study aims to identify the effects of BTX on speech‐related cognitive load and the association of cognitive load with voice‐related quality of life.

Methods

A prospective study of ADLD patients undergoing BTX treatment was conducted. NASA Task Load Index (NASA‐TLX), the Voice‐Related Quality of Life (VRQOL) scale, and voice recordings were obtained on the day of, 1 week after, and 4–6 weeks after BTX injection. Auditory‐perceptual evaluation of the voice samples was performed by four speech‐language pathologists.

Results

Twenty‐one patients completed all measures and voice recordings. Mental and physical demand subscales, derived from the NASA‐TLX, decreased by 4–6 weeks ( p = 0.001 and 0.019, respectively). Median VRQOL improved from 40 to 68 by 4–6 weeks post injection ( p < 0.001). On multilevel multiple linear regression, mental demand and overall voice quality correlated with VRQOL ( p = 0.003 and 0.001, respectively), but physical demand did not ( p = 0.16).

Conclusions

Laryngeal BTX injection reduces cognitive load associated with speaking in ADLD patients. Cognitive load may be more predictive of voice‐related quality of life than the physical effort associated with speaking. Level of Evidence 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal DiseasesCognitionDystoniaBotulinum Toxins, Type ANeuromuscular AgentsBotulinum ToxinsSpeechHumansMaleFemaleProspective StudiesMiddle AgedQuality of LifeVoice QualityAdultAgedTreatment OutcomeLaryngeal Muscles

Stichwörter der Autor:innen

cognitive loadlaryngeal dystoniamental effortquality of lifespasmodic dysphonia

Substanzen

Botulinum Toxins, Type ANeuromuscular AgentsBotulinum Toxins

Autor:innen und Institutionen

  • Department of Otolaryngology- Head and Neck Surgery, University of Washington, Seattle, Washington, USA.
  • University of California, Berkeley, School of Public Health, Berkeley, California, USA.
  • Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Joseph Chang, Tanya K Meyer

Förderung

  • National Center for Advancing Translational Science of the National Institutes of Health

Zitieren

APA

Chang, J., Ovbiebo, N., Lo, C. H., Knutson, M., Sauder, C., Wilson, E., Meyer, T. K., & Eadie, T. L. (2026). Botulinum Toxin Treatment for Adductor Laryngeal Dystonia Reduces Speech‐Related Cognitive Load. The Laryngoscope, 136(5), 2242-2247. https://doi.org/10.1002/lary.70310

Vancouver

Chang J, Ovbiebo N, Lo CH, Knutson M, Sauder C, Wilson E, et al. Botulinum Toxin Treatment for Adductor Laryngeal Dystonia Reduces Speech‐Related Cognitive Load. The Laryngoscope. 2026;136(5):2242-2247. doi:10.1002/lary.70310

BibTeX
@article{Chang2026,
  author = {Chang, Joseph and Ovbiebo, Nede and Lo, Christine H and Knutson, Madeline and Sauder, Cara and Wilson, Emily and Meyer, Tanya K and Eadie, Tanya L},
  title = {Botulinum Toxin Treatment for Adductor Laryngeal Dystonia Reduces Speech‐Related Cognitive Load},
  journal = {The Laryngoscope},
  year = {2026},
  volume = {136},
  number = {5},
  pages = {2242--2247},
  doi = {10.1002/lary.70310}
}
Kostenlos starten →